Data as of Jan 27
| -0.30 / -1.20%|
The 7 analysts offering 12-month price forecasts for Aegerion Pharmaceuticals Inc have a median target of 24.00, with a high estimate of 35.00 and a low estimate of 14.00. The median estimate represents a -2.60% decrease from the last price of 24.64.
The current consensus among 8 polled investment analysts is to Hold stock in Aegerion Pharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.